Financials
- Market Capitalization 3.19 B
- Employee 145
- Founded 2015
- CEO N/A
- Website www.ideayabio.com
- Headquarter Delaware, United States
- FIGI BBG00CTZ4D83
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-27.01
Relación precio/flujo de caja
13.99
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1656 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 32.35 USD | -2.62% | -9.96% | +31.40% | +10.26% | 3.19 B USD | ||
| 1662 | BEAM Beam Therapeutics Inc. - Common Stock | 31.26 USD | +0.84% | -13.60% | +4.72% | +46.49% | 3.22 B USD | ||
| 1687 | ELVN Enliven Therapeutics, Inc. - Common Stock | 51.44 USD | +1.12% | +1.22% | +12.73% | +148.98% | 3.13 B USD | ||
| 1701 | CLDX Celldex Therapeutics, Inc. - Common Stock | 38.68 USD | +0.39% | -0.31% | +21.94% | +42.00% | 3.04 B USD |